Most Favored Nation Pricing
Search documents
Trump Requests 17 Pharmaceutical Companies to Lower Costs | WSJ
WSJ News· 2025-07-31 20:10
Drug Pricing Discrepancy - Brand-name drug prices in the US are more than three times higher than in other developed nations [1][2] - The administration aims to end this burden on American families [2] Proposed Solutions and Demands - The administration rejects proposals that shift blame and request billions of dollars in handouts to the industry [3] - The administration demands immediate relief from inflated drug prices and an end to the free ride on American innovation [3] - Drug manufacturers are called upon to extend most favored nation pricing to Medicaid [4] - Drug manufacturers are called upon to guarantee most favored nation pricing for newly launched drugs [4] - Drug manufacturers are called upon to return increased revenues abroad to American patients and taxpayers [4] - Drug manufacturers are called upon to provide for direct purchasing at most favored nation pricing [4] Potential Actions - The administration will deploy every tool to protect American families from abusive drug pricing practices if manufacturers refuse to comply [4]
Trump says he asked 17 drugmakers to take steps to cut U.S. prices within 60 days
CNBC Television· 2025-07-31 19:00
Government Policy & Regulation - US President Trump is urging 17 pharmaceutical manufacturers to voluntarily lower US prescription drug prices within 60 days to match global prices [1] - The call includes extending most favored nation (MFN) pricing to Medicaid [2] - Guaranteeing MFN pricing for newly launched drugs is also requested [2] - The request includes returning increased revenues from abroad to American patients and taxpayers [2] - Direct purchasing at MFN pricing is another point in the request [2] Industry Impact & Challenges - Implementing MFN pricing for newly launched drugs presents challenges, as US is often the initial launch market [3] - The industry will be watching the responses of companies like Lily, Pfizer, and AbbVie [4]
Trump posts letters to 17 pharmaceutical companies about drug prices
CNBC Television· 2025-07-31 18:12
Well, pharma stocks are on the move as well. Our Angelica Peebles has that story. Angelica.>> Hey, John. Well, President Trump is sending letters to 17 pharmaceutical manufacturers calling on those manufacturers to take voluntary actions within the next 60 days to lower the price of prescription drugs in the US to similar prices around the world. So, he's calling for four things.He wants these companies to extend most favored nation pricing to Medicaid. He also wants them to guarantee MFN pricing for newly ...